Core Position: GRTS (6) Allocation meter: (lowest) 1, 2, 3, 4, 5 (highest) GRTS has received a 6 following the recent halving of the companies value on what we conclude to be compelling data and … [Read more...] about GRTS
Premium
GRTS
Topic of the Week | Royalty Financing
Royalty financing is a strategy that allows (typically) a small cap company to gain access to capital for launching a product in exchange for a percentage of sales generated after launch. Essentially, … [Read more...] about Topic of the Week | Royalty Financing
BioCryst Pharmaceuticals (BCRX) 2Q21 Earnings Highlights
This morning our baby BCRX reported stellar 2Q21 earnings beating our internal expectations as well as those set by Wall Street. Key takeaways: Orladeyo launch maintained momentum and trajectory from … [Read more...] about BioCryst Pharmaceuticals (BCRX) 2Q21 Earnings Highlights
GRTS Goldman Sachs Investor Conference 2021 Transcript
Participants: Salveen Richter (SR) Andrew Allen (AA) SR: Hi good morning everyone my name is Salveen Richter, a Senior Biotech Analyst at Goldman Sachs thank you for joining us. We are … [Read more...] about GRTS Goldman Sachs Investor Conference 2021 Transcript
Topic of the Week | Antibody Drug Conjugates
When it comes to the treatment of cancer, there are a variety of modalities oncologists have in their arsenal by which to treat patients. This depends upon the stage (or how progressed the disease is) … [Read more...] about Topic of the Week | Antibody Drug Conjugates
Topic of the Week | Enzyme Replacement Therapies
Enzyme replacement therapy (abbreviated ERT) is a rather large market that addresses many rare diseases. Oftentimes, patients with these diseases have a genetic defect whereby their body either does … [Read more...] about Topic of the Week | Enzyme Replacement Therapies
Gene Therapy Exciting, But Early
Gene therapy involves inserting genetic material into cells to prevent, cure, or correct a disease caused by genetic abnormalities whereas gene editing involves making actual changes to the genetic … [Read more...] about Gene Therapy Exciting, But Early
Kintara Therapeutcis (NASDAQ: KTRA)….
Since our last article discussing Kintara Therapeutics (NASDAQ: KTRA) underappreciated value proposition to investors, CEO Saiid Zarrabian has solidified the company’s position for growth in 2021 and … [Read more...] about Kintara Therapeutcis (NASDAQ: KTRA)….
GRTS Trades at Enterprise Value With a Potential Covid-19 Variant Answer
With over 500K Americans dead since the outbreak of the COVID-19 pandemic and only modest easing of restrictions after a year of lockdowns despite a nationwide vaccine rollout, people are looking for … [Read more...] about GRTS Trades at Enterprise Value With a Potential Covid-19 Variant Answer
BCX9930: Priceless
We offer an equity analysis subscription service with; nightly email, sms alerts, in depth reports and more. Try us out with a free trial and cancel anytime to see if we're a good fit for your needs! … [Read more...] about BCX9930: Priceless
You must be logged in to post a comment.